Research article · 27 Feb 2026
Conference abstractPublished 2022
Innovative therapies for Alzheimer's disease: Progressing beyond Amyloid and Tau
NYU Long Island School of Medicine, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Alzheimer’s disease (AD) is an incurable progressive neurodegenerative disorder that results in memory loss and impaired learning, judgment, communication, and cognitive abilities. AD is the most common cause of dementia and one of the greatest healthcare challenges worldwide. Prescription drugs approved for use in AD patients help to manage symptoms, but do not change the course of the disease. A hallmark of AD is the accumulation of misfolded protein aggregates of tau and amyloid in the brain. Extensive research has been carried out for the development of treatments directed at reducing the burden of these proteins, but the results have been costly and disappointing. Novel approaches that can lead to real breakthroughs are urgently needed. While there has been progress in designing blood and CSF-based predictive and diagnostic biomarkers, the etiopthogenesis of AD remains unclear. In order to develop efficacious treatments, it is essential to understand underlying mechanisms at the molecular level. New tools are rapidly becoming available that will allow deeper understanding of cellular processes disrupted in AD neurons so that corrective action can be targeted specifically and with precision. Methodologies being considered to prevent or slow neuronal damage would address abnormalities in energy metabolism, increased oxidative stress, neuroinflammation and DNA damage. Successful therapy would result in preservation of neural connectivity, neuronal densities and synaptic signalling. Dr. Reiss will discuss potential innovative, feasible approaches to AD treatment building upon current and evolving knowledge of the AD landscape. She will offer new perspectives for ground-breaking research into AD treatment.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Neuroscience & Clinical Research.
Commentary · 28 Jun 2024
Cellular Responses in Neural Pathology: Neurons, Neuroglia and Connective Tissues
Short communication · 28 Jun 2024
Brain Health Across the Lifespan: Strategies for Cognitive Vitality
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neuroscience & Clinical Research
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Allison B. Reiss”
